OptimizeRx Expands Direct-to-Patient Reach, Partnering with Epion Health to Provide Adherence and Affordability Support at Po...
2020年9月15日 - 8:31PM
OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital
health solutions for life science companies, physicians and
patients, has partnered with Epion Health, a leader in digital
patient engagement solutions, to give patients direct access to
savings programs sponsored by life science companies.
Patients at health systems and medical groups
across the nation using Epion’s recently announced Epion Patient
Services™ – a feature of its digital check-in solution, Epion
Check-In™ – will gain access to the OptimizeRx digital health and
communications platform to receive available savings offers. For
the first time, patients will be able to opt in to connect with
OptimizeRx while checking in for their appointment from their
desktop or mobile device, either at the point-of-care or from home.
After opt-in, patients will see cost-saving opportunities for their
prescribed medications based on their electronic health record.
According to the Annals of Internal Medicine,
patients and physicians have long expressed the desire to talk
about the cost of care in order to determine what works best for
the patient, but have lacked the tools that would support such
conversations. Now, with information about drug savings programs
made available to patients before or at the point-of-care, they can
proactively discuss cost with their healthcare provider. Likewise,
providers are now better equipped to address affordability as a
critical component of treatment.
"Our providers have identified prescription cost
savings as one of the highest priorities for Epion Patient
Services,” said Josh Schwartz, chief business development officer
at Epion Health. “Combining OptimizeRx’s proven platform with
Epion’s ability to present relevant, meaningful, and timely content
to patients, we are able to address this need head-on by rapidly
deploying a solution for prescription savings. Together, we can
improve affordability, adherence, and satisfaction – and ultimately
patient outcomes.”
Miriam Paramore, president of OptimizeRx,
commented: “The innovative way Epion Health leverages digital
technology to improve patient access and engagement makes our new
partnership a great match. At OptimizeRx, we’re committed to
enabling better health outcomes by facilitating the flow of crucial
communication among healthcare stakeholders. This new ability to
communicate directly at the point-of-care empowers patients to have
meaningful discussions with their doctors and make more informed
decisions. This also further scales our network of patients and
enhances the value and revenue of our enterprise offerings in the
near term.”
This expansion of the OptimizeRx digital health
platform represents another significant new point of engagement
with patients for the company’s life science customers. Epion
Check-In is utilized by leading electronic health systems, supports
more than 10 million patient appointments annually, and is ranked
number one in its category due to the system’s ease of use and high
return on investment.
Epion and OptimizeRx expect to complete the
integration of their platforms and begin offering integrated
services to providers and patients next month.
About Epion Health
Epion Health is a leader in digital patient
engagement solutions that empower providers to deliver high-quality
care that’s convenient, accessible, efficient and profitable. Our
secure, HIPAA-compliant platform makes it easy to connect with
patients any time, from anywhere, at all points along the care
journey. Epion’s commitment to innovation and exceptional customer
service has made us a top-rated, trusted partner to healthcare
organizations across the nation.
For more information, visit
www.epionhealth.com.
About OptimizeRx
OptimizeRx is a digital health company that
provides communications solutions for life science companies,
physicians and patients. Connecting over half of healthcare
providers in the U.S. and millions of patients through a
proprietary network, the OptimizeRx digital health platform helps
patients afford and stay on medications. The platform unlocks new
patient and physician touchpoints for life science companies along
the patient journey, from point-of-care, to retail pharmacy,
through mobile patient engagement.
For more information, follow the company
on Twitter, LinkedIn or
visit www.optimizerx.com.
Important Cautions Regarding Forward
Looking Statements This press release contains
forward-looking statements within the definition of Section 27A of
the Securities Act of 1933, as amended, and such as in section 21E
of the Securities Act of 1934, as amended. These forward-looking
statements should not be used to make an investment decision. The
words 'estimate,' 'possible' and 'seeking' and similar expressions
identify forward-looking statements, which speak only as to the
date the statement was made. The company undertakes no obligation
to publicly update or revise any forward-looking statements,
whether because of new information, future events, or otherwise.
Forward-looking statements are inherently subject to risks and
uncertainties, some of which cannot be predicted, or quantified.
Future events and actual results could differ materially from those
set forth in, contemplated by, or underlying the forward-looking
statements. The risks and uncertainties to which forward-looking
statements are subject include, but are not limited to, the effect
of government regulation, competition and other material risks.
OptimizeRx Contact Doug Baker, CFOTel
(248) 651-6568 (x807)dbaker@optimizerx.com
Media Relations
Contact Maira Alejandra, Media Relations ManagerTel
(754) 245-7070 malejandra@optimizerx.com
Investor Relations
Contact Ron Both, CMA Tel (949)
432-7557 oprx@cma.team
OptimizeRx (NASDAQ:OPRX)
過去 株価チャート
から 6 2024 まで 7 2024
OptimizeRx (NASDAQ:OPRX)
過去 株価チャート
から 7 2023 まで 7 2024